Regeneron Pharmaceuticals Statistics
Total Valuation
REGN has a market cap or net worth of $63.78 billion. The enterprise value is $48.86 billion.
Market Cap | 63.78B |
Enterprise Value | 48.86B |
Important Dates
The last earnings date was Tuesday, April 29, 2025, before market open.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | May 20, 2025 |
Share Statistics
REGN has 105.67 million shares outstanding. The number of shares has increased by 0.13% in one year.
Current Share Class | 103.85M |
Shares Outstanding | 105.67M |
Shares Change (YoY) | +0.13% |
Shares Change (QoQ) | -2.28% |
Owned by Insiders (%) | 3.64% |
Owned by Institutions (%) | 91.01% |
Float | 101.65M |
Valuation Ratios
The trailing PE ratio is 15.31 and the forward PE ratio is 16.80. REGN's PEG ratio is 2.66.
PE Ratio | 15.31 |
Forward PE | 16.80 |
PS Ratio | 4.61 |
Forward PS | 4.20 |
PB Ratio | 2.18 |
P/TBV Ratio | 2.26 |
P/FCF Ratio | 20.56 |
P/OCF Ratio | 16.13 |
PEG Ratio | 2.66 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.93, with an EV/FCF ratio of 15.75.
EV / Earnings | 10.86 |
EV / Sales | 3.47 |
EV / EBITDA | 10.93 |
EV / EBIT | 12.29 |
EV / FCF | 15.75 |
Financial Position
The company has a current ratio of 4.93, with a Debt / Equity ratio of 0.09.
Current Ratio | 4.93 |
Quick Ratio | 3.90 |
Debt / Equity | 0.09 |
Debt / EBITDA | 0.60 |
Debt / FCF | 0.87 |
Interest Coverage | 83.17 |
Financial Efficiency
Return on equity (ROE) is 15.96% and return on invested capital (ROIC) is 8.04%.
Return on Equity (ROE) | 15.96% |
Return on Assets (ROA) | 6.91% |
Return on Invested Capital (ROIC) | 8.04% |
Return on Capital Employed (ROCE) | 11.70% |
Revenue Per Employee | $932,457 |
Profits Per Employee | $297,849 |
Employee Count | 15,106 |
Asset Turnover | 0.39 |
Inventory Turnover | 2.44 |
Taxes
In the past 12 months, REGN has paid $484.90 million in taxes.
Income Tax | 484.90M |
Effective Tax Rate | 9.73% |
Stock Price Statistics
The stock price has decreased by -36.93% in the last 52 weeks. The beta is 0.43, so REGN's price volatility has been lower than the market average.
Beta (5Y) | 0.43 |
52-Week Price Change | -36.93% |
50-Day Moving Average | 633.36 |
200-Day Moving Average | 837.06 |
Relative Strength Index (RSI) | 50.94 |
Average Volume (20 Days) | 1,246,821 |
Short Selling Information
The latest short interest is 2.60 million, so 2.46% of the outstanding shares have been sold short.
Short Interest | 2.60M |
Short Previous Month | 2.79M |
Short % of Shares Out | 2.46% |
Short % of Float | 2.56% |
Short Ratio (days to cover) | 2.38 |
Income Statement
In the last 12 months, REGN had revenue of $14.09 billion and earned $4.50 billion in profits. Earnings per share was $39.43.
Revenue | 14.09B |
Gross Profit | 6.87B |
Operating Income | 3.98B |
Pretax Income | 4.78B |
Net Income | 4.50B |
EBITDA | 4.47B |
EBIT | 3.98B |
Earnings Per Share (EPS) | $39.43 |
Balance Sheet
The company has $8.35 billion in cash and $2.70 billion in debt, giving a net cash position of $14.92 billion or $141.21 per share.
Cash & Cash Equivalents | 8.35B |
Total Debt | 2.70B |
Net Cash | 14.92B |
Net Cash Per Share | $141.21 |
Equity (Book Value) | 29.39B |
Book Value Per Share | 277.50 |
Working Capital | 14.01B |
Cash Flow
In the last 12 months, operating cash flow was $3.95 billion and capital expenditures -$851.30 million, giving a free cash flow of $3.10 billion.
Operating Cash Flow | 3.95B |
Capital Expenditures | -851.30M |
Free Cash Flow | 3.10B |
FCF Per Share | $29.35 |
Margins
Gross margin is 48.80%, with operating and profit margins of 28.22% and 31.94%.
Gross Margin | 48.80% |
Operating Margin | 28.22% |
Pretax Margin | 35.38% |
Profit Margin | 31.94% |
EBITDA Margin | 31.74% |
EBIT Margin | 28.22% |
FCF Margin | 22.02% |
Dividends & Yields
This stock pays an annual dividend of $1.76, which amounts to a dividend yield of 0.29%.
Dividend Per Share | $1.76 |
Dividend Yield | 0.29% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 4.46% |
Buyback Yield | -0.13% |
Shareholder Yield | 0.16% |
Earnings Yield | 7.05% |
FCF Yield | 4.86% |
Analyst Forecast
The average price target for REGN is $907.39, which is 50.34% higher than the current price. The consensus rating is "Buy".
Price Target | $907.39 |
Price Target Difference | 50.34% |
Analyst Consensus | Buy |
Analyst Count | 23 |
Revenue Growth Forecast (5Y) | 7.22% |
EPS Growth Forecast (5Y) | 13.58% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
REGN has an Altman Z-Score of 9.55 and a Piotroski F-Score of 3.
Altman Z-Score | 9.55 |
Piotroski F-Score | 3 |